Type 1 diabetes, on the other hand ... "The standard practice is to have patients with diabetes on once-a-day basal insulin, which can be long-acting or ultra-long-acting. Rapid-acting is usually ...

Involving 4,000 adult patients with type 1 or type 2 diabetes, the programme comprised six global Phase IIIa studies assessing the safety and efficacy of once-weekly basal insulin icodec. The new ...

where it can be used for type 2 only. “We believe in the potential of once-weekly basal insulin icodec for those living with diabetes who require basal insulin therapy,” said Martin Lange ...

The rise in type 2 diabetes has become a significant public health concern in recent years. This form of diabetes happens ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

'No Excuses': Training for the Olympics with Type 1 Diabetes Drs Michael Riddell and Anne Peters speak with Gary C. Hall, Jr, about competing and winning 10 Olympic medals with type 1 diabetes.

In another trial of 91 patients with uncontrolled type 2 diabetes on basal/premixed insulin, Gan & Lee's once-daily GZR101 lowered HbA1c by 1.56%, winning out over the 1.31% reduction in the once ...

GLP-1 and GIP increase insulin biosynthesis and secretion ... improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose.

compared to once-daily insulin degludec in adults with type 1 diabetes who require daily basal and multiple daily mealtime insulin injections. The data were published in The Lancet and ...

Metformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial ... and improves insulin sensitivity by increasing ...

an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old and above. Tidepool, an open-source diabetes non-profit founded in 2013 and driving ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...